Zhefeng Liu Lin Wu Jun Cao Zhe Yang Chengzhi Zhou Liming Cao Hao Wu Haibo Shen Meiling Jin Yong Zhang Xinru Mao Jianxing Xiang Ke Ma Bing Li Tengfei Zhang Yi Hu
10.2147/OTT.S173391
Onco Targets Ther
2018 Oct 23;11:7323-7331.
erbb2 afatinib heterogeneity lung cancer survival
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/30425522/
PMC6205822
30425522
Clinical characterization of ERBB2 exon 20 insertions and heterogeneity of outcomes responding to afatinib in Chinese lung cancer patients
2018